Quantitative Investment Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Quantitative Investment Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,905	Closed	-$271K	–	908
2017 Q2	$271K	Buy	+1,905	New	+$294K	﹤0.01%	648
2017 Q1	–	Sell	-2,265	Closed	-$182K	–	988
2016 Q4	$182K	Buy	+2,265	New	+$179K	﹤0.01%	754
2016 Q2	–	Sell	-2,070	Closed	-$191K	–	994
2016 Q1	$191K	Buy	+2,070	New	+$207K	0.01%	705
2015 Q4	–	Sell	-3,080	Closed	-$459K	–	905
2015 Q3	$459K	Buy	+3,080	New	+$2.26M	0.03%	459

Other funds holding TTPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantitative Investment Management's TTPH Position: Q3 2017 in Review

Quantitative Investment Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2017, closing a stake of 1,905 shares — an estimated $271K sold.

Quantitative Investment Management first reported a position in TTPH in Q3 2015 and held it in 4 quarters. The position peaked at $459K in Q3 2015. 94 funds tracked by Wall St. Rank hold TTPH as of Q3 2017.

Quantitative Investment Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
Quantitative Investment Management sold 1,905 Tetraphase Pharmaceuticals, Inc. shares in Q3 2017, an estimated $271K.
Quantitative Investment Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and held it in 4 quarters.
Quantitative Investment Management's Tetraphase Pharmaceuticals, Inc. position peaked at $459K in Q3 2015.
94 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2017.

Based on Quantitative Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.